ALNY
NASDAQStockAlnylam Pharmaceuticals, Inc.
$313.45-3.77 (-1.19%)
52-Week Range
$224.32
$491.22
Key Stats
Market Cap
41.6B
P/E Ratio
155.95
Dividend Yield
—
Beta
0.38
Volume
526.0K
Avg Volume
1.5M
Performance
1M
+2.84%
3M
-18.97%
6M
-31.21%
YTD
-20.73%
1Y
+31.22%
3Y
+70.78%
5Y
+117.10%
Price Chart
ETF Exposure
ALNY is held by 460 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GERM | ETFMG Treatments, Testing and Advancements ETF | 11.39% |
| MNTL | Tema Neuroscience And Mental Health ETF | 7.74% |
| MSGR | Direxion mRNA ETF | 6.45% |
| PBE | Invesco Biotechnology & Genome ETF | 5.09% |
| MEDX | Horizon Kinetics Medical ETF | 3.96% |
| IBB | iShares Biotechnology ETF | 3.65% |
| QQQN | VictoryShares Nasdaq Next 50 ETF | 3.64% |
| BBH | VanEck Biotech ETF | 3.51% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 3.24% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 3.24% |
| DBX4.DE | Xtrackers MSCI EM Europe, Middle East & Africa ESG Swap UCITS ETF | 3.10% |
| XMXD.L | Xtrackers MSCI EM Europe, Middle East & Africa ESG Swap UCITS ETF 1C | 3.10% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 2.88% |
| TYNE | Direxion Nanotechnology ETF | 2.84% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 2.82% |
| GNOG.L | Global X - Genomics & Biotechnology UCITS ETF | 2.72% |
| GNOM.L | Global X - Genomics & Biotechnology UCITS ETF | 2.72% |
| GNOM | Global X - Genomics & Biotechnology ETF | 2.53% |
| HELX | Franklin Genomic Advancements ETF | 2.50% |
| FDG | American Century Focused Dynamic Growth ETF | 2.46% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 2.32% |
| ROCI | ROC ETF | 1.94% |
| XMAF.L | Xtrackers MSCI Africa Top 50 Swap UCITS ETF 1C | 1.93% |
| XMKA.DE | Xtrackers MSCI Africa Top 50 Swap UCITS ETF 1C | 1.93% |
| PFUT | Putnam Sustainable Future ETF | 1.86% |
| QQEW | First Trust Nasdaq-100 Select Equal Weight ETF | 1.76% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.53% |
| JMID | Janus Henderson Mid Cap Growth Alpha ETF | 1.52% |
| BMED | iShares Health Innovation Active ETF | 1.47% |
| CAML | Congress Large Cap Growth ETF | 1.42% |
| QQXT | First Trust NASDAQ-100 Ex-Technology Sector Index Fund | 1.42% |
| IWP | iShares Russell Mid-Cap Growth ETF | 1.41% |
| MID | American Century Mid Cap Growth Impact ETF | 1.32% |
| BBP | Virtus Biotech ETF | 1.27% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 1.20% |
| VOT | Vanguard Mid-Cap Growth ETF | 1.18% |
| NWLG | Nuveen Winslow Large-Cap Growth ESG | 1.16% |
| DRUP | GraniteShares Nasdaq Select Disruptors ETF | 1.15% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 1.14% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.11% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 1.10% |
| MEDI | Harbor Health Care ETF (MEDI) | 1.10% |
| NXTI | Simplify NEXT Intangible Core Index ETF | 1.07% |
| CURE.AX | Global X - S&P Biotech ETF | 1.00% |
| XBI | State Street SPDR S&P Biotech ETF | 1.00% |
| QNXT | iShares Nasdaq-100 ex Top 30 ETF | 0.98% |
| CGGR | Capital Group Growth ETF | 0.89% |
| MXDU | Nationwide Maximum Diversification U.S. Core Equity ETF | 0.83% |
| QQQE | Direxion NASDAQ-100 Equal Weighted Index ETF | 0.82% |
| FMDE | FIDELITY ENHANCED MID CAP ETF | 0.80% |
Page 1 of 10Next
About ALNY ETF Exposure
Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.